| LLYELI LILLY & Co | 417,282 | $383.8M |
| ABBVAbbVie Inc. | 1,144,668 | $249.0M |
| GILDGILEAD SCIENCES, INC. | 1,670,288 | $232.8M |
| MCKMcKesson Corporation | 239,664 | $207.4M |
| JNJJOHNSON & JOHNSON | 798,815 | $195.3M |
| MRKMerck & Co., Inc. | 1,322,654 | $159.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 186,388 | $144.0M |
| AMGNAMGEN INC | 395,351 | $139.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 228,915 | $102.2M |
| ONCBeOne Medicines Ltd. | 259,731 | $77.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 224,330 | $74.2M |
| BIIBBIOGEN INC. | 381,768 | $70.0M |
| INSMINSMED Inc | 401,735 | $65.7M |
| ABTABBOTT LABORATORIES | 624,438 | $64.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 232,839 | $63.0M |
| COGTCogent Biosciences, Inc. | 1,516,297 | $58.4M |
| RVMDREVOLUTION MEDICINES, INC. | 580,677 | $56.5M |
| PFEPFIZER INC | 1,992,586 | $56.0M |
| ROIVRoivant Sciences Ltd. | 2,001,976 | $55.5M |
| ZTSZoetis Inc. | 458,854 | $54.2M |
| BMYBRISTOL MYERS SQUIBB CO | 821,620 | $49.8M |
| MEDPMedpace Holdings Inc. | 103,349 | $49.6M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 84,948 | $44.5M |
| BNTXBioNTech SE | 488,367 | $43.4M |
| MIRMMirum Pharmaceuticals, Inc. | 464,216 | $42.9M |
| RYTMRHYTHM PHARMACEUTICALS, INC. | 464,340 | $40.4M |
| NUVLNuvalent, Inc. | 391,306 | $40.1M |
| ARGXARGENX SE | 54,148 | $39.5M |
| IQVIQVIA Holdings Inc. | 226,794 | $38.7M |
| UTHRUNITED THERAPEUTICS Corp | 63,066 | $37.4M |
| IDYAIDEAYA Biosciences, Inc. | 1,107,708 | $36.9M |
| CGONCG Oncology, Inc. | 542,036 | $36.7M |
| IONSIONIS PHARMACEUTICALS INC | 484,053 | $36.3M |
| NBIXNEUROCRINE BIOSCIENCES INC | 275,064 | $36.2M |
| IDXXIDEXX LABORATORIES INC /DE | 64,015 | $36.0M |
| TERNTerns Pharmaceuticals, Inc. | 631,636 | $33.3M |
| INCYIncyte Corp. | 342,042 | $32.2M |
| SYRESpyre Therapeutics, Inc. | 610,282 | $30.8M |
| CRNXCrinetics Pharmaceuticals, Inc. | 830,961 | $30.2M |
| XENEXenon Pharmaceuticals Inc. | 476,494 | $27.7M |
| TNGXTango Therapeutics, Inc. | 1,269,246 | $26.6M |
| ARQTArcutis Biotherapeutics, Inc. | 1,086,651 | $25.6M |
| DFTXDefinium Therapeutics Inc. | 1,293,629 | $24.4M |
| ELVNEnliven Therapeutics, Inc. | 594,079 | $23.3M |
| RAREUltragenyx Pharmaceutical Inc. | 1,096,182 | $23.0M |
| CYTKCYTOKINETICS INC | 335,208 | $22.1M |
| BCRXBIOCRYST PHARMACEUTICALS INC | 2,286,841 | $21.8M |
| MLYSMineralys Therapeutics, Inc. | 801,904 | $21.7M |
| SNDXSyndax Pharmaceuticals Inc | 925,332 | $21.6M |
| DNLIDenali Therapeutics Inc. | 1,099,845 | $21.1M |
| BBIOBridgeBio Pharma, Inc. | 278,888 | $20.7M |
| PRAXPraxis Precision Medicines, Inc. | 63,628 | $20.5M |
| DGXQuest Diagnostics Incorporated | 104,136 | $20.4M |
| ORKAOruka Therapeutics, Inc. | 411,006 | $20.2M |
| VERAVera Therapeutics, Inc. | 475,335 | $19.1M |
| APGEApogee Therapeutics, Inc. | 223,541 | $18.8M |
| PCVXVaxcyte, Inc. | 315,022 | $18.3M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 213,522 | $17.9M |
| RCUSArcus Biosciences, Inc. | 790,613 | $17.1M |
| IMVTImmunovant, Inc. | 680,372 | $16.9M |
| KYMRKymera Therapeutics, Inc. | 201,672 | $16.8M |
| STOKStoke Therapeutics, Inc. | 502,020 | $16.3M |
| MLTXMoonLake Immunotherapeutics | 818,126 | $15.2M |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 86,430 | $14.9M |
| EWTXEdgewise Therapeutics, Inc. | 447,416 | $14.1M |
| TEVATeva Pharmaceutical Industries Limited | 467,562 | $14.1M |
| VRDNViridian Therapeutics, Inc.\DE | 711,739 | $13.9M |
| IMNMImmunome Inc. | 539,882 | $11.8M |
| CAHCardinal Health Inc. | 55,680 | $11.8M |
| MRNAModerna, Inc. | 230,824 | $11.7M |
| OLMAOlema Pharmaceuticals, Inc. | 759,513 | $11.3M |
| SRRKScholar Rock Holding Corp | 225,998 | $11.1M |
| TVTXTravere Therapeutics, Inc. | 369,995 | $11.0M |
| ELVElevance Health Inc. | 36,861 | $10.8M |
| SMMTSummit Therapeutics Inc. | 540,662 | $10.3M |
| VIRVir Biotechnology, Inc. | 1,135,763 | $10.2M |
| SIONSionna Therapeutics, Inc. | 236,813 | $9.5M |
| SLNOSOLENO THERAPEUTICS INC | 281,620 | $9.4M |
| TRVITrevi Therapeutics, Inc. | 773,620 | $9.2M |
| CLDXCelldex Therapeutics, Inc. | 278,888 | $8.8M |
| MBXMBX Biosciences, Inc. | 294,374 | $8.8M |
| LEGNLegend Biotech Corp | 470,292 | $8.5M |
| MAZEMaze Therapeutics, Inc. | 278,167 | $8.3M |
| NRIXNurix Therapeutics, Inc. | 534,259 | $8.3M |
| GHGuardant Health Inc. | 89,216 | $8.2M |
| IMCRImmunocore Holdings plc | 269,729 | $8.1M |
| OCULOCULAR THERAPEUTIX, INC | 949,216 | $8.0M |
| GMOptec International, Inc. | 98,578 | $7.3M |
| ALLOAllogene Therapeutics, Inc. | 2,997,318 | $7.3M |
| ORICOric Pharmaceuticals, Inc. | 574,085 | $7.3M |
| GERNGERON CORP | 3,921,476 | $5.8M |
| RAPPRapport Therapeutics, Inc. | 185,925 | $5.8M |
| CORCencora Inc. | 17,841 | $5.6M |
| GMEDGlobus Medical Inc. | 58,646 | $5.1M |
| BCAXBicara Therapeutics Inc. | 238,822 | $4.8M |
| GEHCGE HealthCare Technologies Inc. | 64,841 | $4.6M |
| ABVXAbivax SA | 36,061 | $4.0M |
| REPLReplimune Group, Inc. | 394,027 | $3.0M |
| WSTWest Pharmaceutical Services Inc. | 9,124 | $2.3M |
| FBRXForte Biosciences, Inc. | 84,803 | $2.2M |
| HALOHALOZYME THERAPEUTICS, INC. | 31,075 | $2.0M |
| FHTXFoghorn Therapeutics Inc. | 313,765 | $1.5M |
| CNTACentessa Pharmaceuticals plc | 36,254 | $1.4M |
| ZBHZimmer Biomet Holdings Inc. | 14,531 | $1.3M |
| PMPhilip Morris International Inc | 5,482 | $906K |